Companies/US/ALEC

ALECTOR, INC.

Last · —$1.88+0.01 (+0.53%)live · yahoo · 2h ago
Vol 1.27M ≈ 2.42M
Market cap$209.92M—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session

Issuer

Legal nameALECTOR, INC.
HQUnited States (US)
ListingUS ALEC
ISINUS0144421072
SectorHealthcare
IndustryBiotechnology & Medical Research
SIC2836
CurrencyUSD
Entity registrysec:0001653087
CIK0001653087
Employees103
AddressAlector, Inc. 131 Oyster Point Boulevard 94080-2029, South San Francisco +415 231 5660
Headline financial metrics
Revenue$13.9M
Operating income$-49.3M
Net income$-45.9M
Free cash flow$-84.2M
Operating margin-355.7%
Net margin-331.2%
PeriodTTM 2026-06-30
Loading chart…

OpenFilings analyst

Our analyst

10-K · 2026-02-25

From latest 10-K · 2026-02-25

  • Sbc Revenue High
  • Operating Cf Burn
  • Net Margin Sharply Negative
  • Cash Conversion Weak
  • Cash Runway Low
  • Accumulated Deficit High
  • Rd Intensity High

Red flags

  • Sbc Revenue High — SBC/Revenue 126.7%
  • Operating Cf Burn — Negative operating cash flow
  • Net Margin Sharply Negative — Net margin -679.2%
  • Cash Conversion Weak — Cash conversion (CFO/Rev) -874.5%
  • Cash Runway Low — Cash runway ~0.4 years
  • Accumulated Deficit High — Accumulated deficit / equity 3172%
  • Rd Intensity High — R&D/Revenue 584.8%

Upcoming earnings

1 event
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.22
Est. revenue
2.4M

Press & signals

1 recent
  • Satelight

    Alector Enters Global License Agreement with Genentech for Brain

Documents

FormReporting forFiledFlags
2026-09-032026-09-040
2026-09-032026-09-040
2026-09-022026-09-040